Weeding out new drugs.
Ewan
Scott
S
D000700:Analgesics / Q000737:chemistry / Q000627:therapeutic use; D019440:Anti-Obesity Agents / Q000737:chemistry / Q000627:therapeutic use; D002186:Cannabinoids / Q000737:chemistry / Q000627:therapeutic use*; D002188:Cannabis / Q000737:chemistry*; D002986:Clinical Trials as Topic; D006801:Humans; D057927:Hydrophobic and Hydrophilic Interactions; D015212:Inflammatory Bowel Diseases / Q000188:drug therapy* / Q000503:physiopathology; D010880:Piperidines / Q000737:chemistry / Q000627:therapeutic use; D011720:Pyrazoles / Q000737:chemistry / Q000627:therapeutic use; D043884:Receptor, Cannabinoid, CB1 / Q000037:antagonists & inhibitors / Q000502:physiology; D043885:Receptor, Cannabinoid, CB2 / Q000502:physiology; D000077285:Rimonabant; D012995:Solubility
D000700:Analgesics; D019440:Anti-Obesity Agents; D002186:Cannabinoids; C409929:O 1057; D010880:Piperidines; D011720:Pyrazoles; D043884:Receptor, Cannabinoid, CB1; D043885:Receptor, Cannabinoid, CB2; D000077285:Rimonabant